Rodriguez Susan
SEC CIK 1812511 · EDGAR
BoughtSold
Most active insiders at HRTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Cusack Thomas | Dir | — | — |
| 2 | Hensley Mark Earl | COO | — | — |
| 3 | Morgan Adam | Dir | — | — |
| 4 | Rosen David Efraim | 10% | — | — |
| 5 | Dissanaike Sharmila | Dir | — | — |
| 6 | Kaseta Michael | Dir | — | — |
| 7 | Christian Waage | Dir | — | — |
| 8 | Duarte Ira | EVP, CFO | — | — |
| 9 | Johnson Craig A | Dir | — | — |
| 10 | Collard Craig A | CEO, Dir | — | — |
Rodriguez Susan made no open-market trades at HRTX in the last 12 months.
Transactions 22
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DA | 2025-02-04 | 2025-01-31 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Rodriguez Susan | Dir | A - Grant | $0.00 | +17.9K | 87.2K | +26% | $0 |
| D | 2025-02-03 | 2025-01-30 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Rodriguez Susan | Dir | A - Grant | $0.00 | +17.9K | 87.2K | +26% | $0 |
| 2024-05-23 | 2024-05-21 | ARDX | ARDELYX, INC. | Rodriguez Susan | Chief Commercial Off | S - Sale | $7.81 | -6,703 | 449.1K | -1% | -$52.4K | |
| 2024-02-22 | 2024-02-20 | ARDX | ARDELYX, INC. | Rodriguez Susan | Chief Commercial Off | S - Sale | $8.75 | -6,928 | 452.8K | -2% | -$60.6K | |
| D | 2024-01-19 | 2024-01-19 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Rodriguez Susan | Dir | A - Grant | $0.00 | +13.9K | 69.2K | +25% | $0 |
| D | 2024-01-18 | 2024-01-16 | ARDX | ARDELYX, INC. | Rodriguez Susan | Chief Commercial Off | A - Grant | $0.00 | +112.8K | 459.7K | +32% | $0 |
| 2023-11-22 | 2023-11-20 | ARDX | ARDELYX, INC. | Rodriguez Susan | Chief Commercial Off | S - Sale | $4.36 | -4,714 | 347.0K | -1% | -$20.6K | |
| 2023-08-23 | 2023-08-21 | ARDX | ARDELYX, INC. | Rodriguez Susan | Chief Commercial Off | S - Sale | $3.55 | -4,733 | 348.7K | -1% | -$16.8K | |
| 2023-05-25 | 2023-05-23 | ARDX | ARDELYX, INC. | Rodriguez Susan | Chief Commercial Off | S - Sale | $3.65 | -4,711 | 353.4K | -1% | -$17.2K | |
| 2023-03-02 | 2023-02-21 | ARDX | ARDELYX, INC. | Rodriguez Susan | Chief Commercial Off | S - Sale | $3.00 | -5,586 | 355.1K | -2% | -$16.8K | |
| D | 2023-01-06 | 2023-01-05 | ARDX | ARDELYX, INC. | Rodriguez Susan | Chief Commercial Off | A - Grant | $0.00 | +78.0K | 360.7K | +28% | $0 |
| D | 2022-12-20 | 2022-12-16 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Rodriguez Susan | Dir | A - Grant | $0.00 | +38.6K | 55.3K | +231% | $0 |
| M | 2022-11-23 | 2022-11-22 | ARDX | ARDELYX, INC. | Rodriguez Susan | Chief Commercial Off | S - Sale | $1.95 | -3,456 | 286.0K | -1% | -$6,738 |
| M | 2022-08-24 | 2022-08-22 | ARDX | ARDELYX, INC. | Rodriguez Susan | Chief Commercial Off | S - Sale | $0.98 | -3,420 | 286.2K | -1% | -$3,352 |
| M | 2022-06-08 | 2022-06-06 | ARDX | ARDELYX, INC. | Rodriguez Susan | Chief Commercial Off | S - Sale | $0.6498 | -43.9K | 289.6K | -13% | -$28.5K |
| 2022-05-23 | 2022-05-20 | ARDX | ARDELYX, INC. | Rodriguez Susan | Chief Commercial Off | S - Sale | $0.67 | -3,425 | 333.5K | -1% | -$2,295 | |
| 2022-02-25 | 2022-02-22 | ARDX | ARDELYX, INC. | Rodriguez Susan | Chief Commercial Off | S - Sale | $0.67 | -3,400 | 333.9K | -1% | -$2,278 | |
| D | 2022-01-12 | 2022-01-06 | ARDX | ARDELYX, INC. | Rodriguez Susan | Chief Commercial Off | A - Grant | $0.00 | +141.0K | 338.0K | +72% | $0 |
| D | 2021-12-23 | 2021-12-22 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Rodriguez Susan | Dir | A - Grant | $0.00 | +10.5K | 16.7K | +167% | $0 |
| 2021-11-24 | 2021-11-22 | ARDX | ARDELYX, INC. | Rodriguez Susan | Chief Commercial Off | S - Sale | $0.99 | -643 | 197.0K | -0.3% | -$636.57 | |
| 2021-10-29 | 2021-10-08 | ARDX | ARDELYX, INC. | Rodriguez Susan | Chief Commercial Off | A - Grant | $0.00 | +150.0K | 197.7K | +315% | $0 | |
| 2021-08-24 | 2021-08-20 | ARDX | ARDELYX, INC. | Rodriguez Susan | Chief Commercial Off | S - Sale | $1.32 | -630 | 44.7K | -1% | -$831.60 |
Purchase Sale Sale after option exercise All abbreviations